Sciomics - Enabling Precision Medicine

High-content affinity proteomics for protein biomarker discovery, translational research, and de-risked drug development across all disease areas.

 

Sciomics is a contract research and biomarker development company specialising in Precision Proteomics. We support pharma, biotech, and academic partners with antibody microarray–based protein profiling and post-translational modification (PTM) screening to generate actionable, decision-enabling data. Our platform helps bridge the translational gap between discovery research and clinical application, enabling target and pathway validation, preclinical model assessment, biomarker discovery, patient stratification, and therapy response prediction across all disease areas. By delivering systems-level protein insights, Sciomics helps de-risk R&D programs, improve biomarker robustness, and accelerate development timelines.

In parallel, Sciomics advances internal multi-protein biomarker development programs, with its most advanced pipeline in Acute Kidney Injury (AKI), validated in large patient cohorts.

 

 

Start Your Project Explore our Services

Illustration showing how biomarker and pathway insights connect precision medicine with precision drug discovery, linking disease understanding, disease mechanisms, drug mode of action, and research models. 
 
Bridging Key Challenges in Translational Proteomics

 

Despite advances in molecular research, many R&D programs face recurring scientific and operational challenges. Sciomics addresses these bottlenecks in protein biomarker discovery and translational research:

  • Limited predictive value of preclinical models
    Preclinical systems often fail to reflect complex human biology, increasing late-stage development risk.
    --> De-risking with deep protein insights
  • Insufficient systems-level protein insight
    Single-marker approaches rarely capture the dynamic signaling networks driving disease progression.
    --> AI-enhanced network proteomics yields decision-ready data
  • Biomarker irreproducibility and lack of robustness
    Low-content methods can lead to inconsistent results and poor clinical validation.
    --> Biomarker signatures deliver highest accuracy and validation success
  • Delayed decision-making due to fragmented workflows
    Separated wet lab, data analysis, and interpretation processes slow development and increase uncertainty.
    --> End-to-end service for immediately usable results
 Challenges and solutions in translational proteomics

Sciomics overcomes these challenges through high-content affinity proteomics combined with integrated bioinformatics and biological interpretation. By uniting study design, antibody microarray–based protein profiling, quantitative data analysis, and scientific reporting within one end-to-end workflow, Sciomics enables robust biomarker discovery and translational decision-making across all disease areas.

Our End-to-End Affinity Proteomics Workflow

 

Our structured end-to-end affinity proteomics workflow ensures robust, high-content protein profiling — from study design and antibody microarray analysis to advanced bioinformatics and biological interpretation — with scientific guidance at every step.

Sciomics end-to-end workflow translates complex protein data into biological insights - from study design over. 

Project Planning & Study Design: We align your research objectives, biomarker hypotheses, assay selection, and sample strategy with our scientific team to ensure optimal study design and translational relevance.

Sample Submission: We process diverse sample types, including plasma, CSF, tissues, cells, organoids, and more — using standardised protocols to ensure reproducible, high-quality data.

Protein Profiling: Using our antibody microarray–based affinity proteomics platform, we perform multiplex protein profiling to capture systems-level signaling patterns and biomarker signatures.

Data Analysis & Reporting: Our advanced statistical and bioinformatic analysis identifies differentially expressed proteins and pathway alterations, delivering a structured, publication-ready study report. 

Data Presentation & Interpretation: We review results with you, interpret biological relevance, refine hypotheses, and discuss next experimental or translational steps to support data-driven decision-making.

Together, we translate complex protein data into actionable biological insights.

Discuss your Project with a dedicated Scientist

 
 

Our High-Content Antibody Microarrays for Protein and Post-Translational Modification Profiling

Sciomics offers high-content affinity proteomics services based on proprietary antibody microarrays for comprehensive protein and post-translational modification (PTM) profiling.
Our arrays enable the simultaneous analysis of hundreds to more than 1,500 proteins — with optional PTM screening — providing pathway-level insights from minimal sample material. From cytokine and immune profiling to complex intracellular signalling and pathway analysis, our portfolio includes the right array for every stage of translational and preclinical research.Overview of Sciomics' Microarrays: scioCyto, scioCD, scioDiscover, scioPhospho, and scioUbi 

scioCyto scioCD scioDiscover scioPhospho scioUbi

Applications of our Affinity Proteomics Platform

Our affinity proteomics platform supports a broad spectrum of translational and preclinical research applications. By enabling high-content protein and PTM profiling, Sciomics generates pathway-level insights to accelerate drug development, biomarker discovery, and Precision Medicine strategies across all disease areas.

Our services are used across a wide range of applications, including:

Preclinical & Mechanistic Research Applications

  • Preclinical drug studies and dose optimisation
  • Mechanism-of-action analysis
  • Target identification and pathway validation
  • Cell differentiation and functional pathway studies
  • Immune profiling and inflammation research

Translational & Biomarker Development Applications

  • Protein Biomarker discovery, verification, and validation
  • Translational biomarker development for clinical research
  • Patient stratification and therapy response prediction
  • Oncology research and tumour microenvironment analysis

   

Compatible Biological Sample Types for Affinity Proteomics 

Sciomics enables high-content protein and PTM profiling across a broad range of biological sample types, including plasma, serum, CSF, tissues, cell lysates, supernatants, and organoid systems. Our antibody microarray platform delivers robust, reproducible results even from minimal sample input, supporting translational and preclinical research applications.

Antibody Microarray Workflow for robust proteomics profiling: Illustration depicting the steps involved in protein profiling using antibody microarrays, from protein isolation and sample labeling to antibody immobilization, sample incubation, image acquisition, and data analysis for the scioDiscover platform.

Explore supported sample types.

Why partner with Sciomics for Affinity Proteomics 

Sciomics combines high-content affinity proteomics with integrated bioinformatics and scientific expertise to deliver robust, decision-enabling protein data.

  • High-Content, Multiplex Protein and PTM Profiling: Simultaneous analysis of hundreds to over 1,500 proteins using antibody microarray–based affinity proteomics.

  • Minimal Sample Input Requirements: Robust and reproducible results from limited and precious clinical or preclinical sample material.

  • Broad Biological Sample Compatibility: Established workflows for plasma, serum, CSF, tissues, cell lysates, organoids, and more.

  • Integrated Bioinformatics and Publication-Ready Reporting: Advanced statistical analysis delivering structured, publication-ready study reports.

  • Dedicated Scientific Partnership: Direct collaboration with experienced scientists supporting study design, data interpretation, and translational strategy.

 

Discuss your Translational Proteomics Study

Whether you are planning a preclinical compound study, a biomarker discovery project, or a basic research experiment, Sciomics supports you with high-content affinity proteomics and publication-ready protein profiling data.

Schedule a Scientific Consultation